MORFĖJUS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,067,804 | 2,420,332 | 2,267,817 | 2,420,942 | 2,701,674 | 2,703,685 | 2,779,049 | 3,458,024 |
| Profit before tax | 367,895 | 624,889 | 423,066 | 483,009 | 426,402 | 353,904 | 451,258 | 1,011,185 |
| Net profit | 312,695 | 531,505 | 359,759 | 409,806 | 362,869 | 298,483 | 383,430 | 845,469 |
| Equity | 1,510,633 | 1,882,138 | 2,081,897 | 2,331,704 | 2,534,572 | 2,614,056 | 2,697,486 | 3,146,854 |
| Liabilities | 617,882 | 606,947 | 381,902 | 1,054,404 | 531,741 | 458,619 | 516,815 | 597,459 |
| Non-current assets | 108,165 | 121,418 | 99,439 | 110,265 | 92,744 | 152,808 | 180,299 | 126,255 |
| Current assets | 2,016,560 | 2,362,450 | 2,357,943 | 3,269,454 | 2,964,704 | 2,909,582 | 3,301,330 | 4,050,467 |
| Total assets | 2,124,725 | 2,483,868 | 2,457,382 | 3,379,719 | 3,057,448 | 3,062,390 | 3,481,629 | 4,176,722 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 373,842 | 384,071 | 457,419 |
| Social insurance contributions | - | - | - | - | - | 69,217 | 79,483 | 84,413 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +15.1% | +17.0% | -6.3% | +6.8% | +11.6% | +0.1% | +2.8% | +24.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 14.7% | 21.4% | 14.6% | 12.1% | 11.9% | 9.7% | 11.0% | 20.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 20.7% | 28.2% | 17.3% | 17.6% | 14.3% | 11.4% | 14.2% | 26.9% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 15.1% | 22.0% | 15.9% | 16.9% | 13.4% | 11.0% | 13.8% | 24.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 17.8% | 25.8% | 18.7% | 20.0% | 15.8% | 13.1% | 16.2% | 29.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.3 | 0.2 | 0.5 | 0.2 | 0.2 | 0.2 | 0.2 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 258,476 | 312,301 | 251,980 | 268,994 | 300,186 | 300,409 | 308,783 | 384,225 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MORFĖJUS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-01-16 | 2025-01-19 | 8792.83 |
MORFĖJUS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-21 | 2026-02-21 | 1.03 |
| 2025-05-01 | 2025-05-06 | 345.26 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MORFEJUS, UAB (code 121920394) is a Private Limited Liability Company active in the wholesale of pharmaceutical and medical goods. In 2025, the company increased revenue to €3.46M, up 24.4% year on year and 27.9% over two years. Net profit rose to €845.5K, compared with €383.4K in 2024 and €298.5K in 2023, showing a clear upward earnings trend. The 2025 profit margin reached 24.4%, supported by stronger operating performance and higher sales. Balance sheet indicators also strengthened: total assets grew to €4.18M, equity to €3.15M, and liabilities to €597.5K. The equity ratio stood at 75.3%, with debt-to-equity at 0.19, indicating a conservative capital structure. Return on equity was 26.9% and return on assets 20.2%. Asset turnover was 0.83x. With revenue per employee at €384.2K and profit per employee at €93.9K, the company shows solid productivity alongside growth in 2025.